The European Association for Percutaneous Cardiovascular Interventions Congress (EuroPCR) aims to draw together cardiologists, surgeons, radiologists, angiologists, industry and allied healthcare partners.
During a four-day course, covering coronary, peripheral, valve and non-coronary cardiac disease, cardiothoracic surgery and vascular surgery, cases will be transmitted live from 17 collaborating centres around the world. The educational sessions will cover ‘the fusion of the pedagogic skills of experienced practitioners and input from younger practitioners’, the organisers report. ‘These highly innovative and interactive sessions are based on a step-by-step decision-making process.’ The focus will be on coronary, carotid and patent foramen ovale percutaneous intervention. Also in the programme will be sessions on tools, techniques or technologies that may make their way into mainstream practice — CTO, bifurcation, new DES and imaging, all again with live case transmission.
Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.
At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.
At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.
.jpg&contenttype=jpeg)
